| Year |
Citation |
Score |
| 2014 |
Bang JW, Khalilzadeh O, Hämäläinen M, Watanabe T, Sasaki Y. Location specific sleep spindle activity in the early visual areas and perceptual learning. Vision Research. 99: 162-71. PMID 24380705 DOI: 10.1016/J.Visres.2013.12.014 |
0.577 |
|
| 2013 |
Esteghamati A, Mousavizadeh M, Noshad S, Shoar S, Khalilzadeh O, Nakhjavani M. Accuracy of anthropometric parameters in identification of high-risk patients predicted with cardiovascular risk models. The American Journal of the Medical Sciences. 346: 26-31. PMID 22986615 DOI: 10.1097/Maj.0B013E31826485De |
0.311 |
|
| 2012 |
Esteghamati A, Morteza A, Zandieh A, Jafari S, Rezaee M, Nakhjavani M, Jamali A, Esteghamati AR, Khalilzadeh O. The value of visfatin in the prediction of metabolic syndrome: a multi-factorial analysis. Journal of Cardiovascular Translational Research. 5: 541-6. PMID 22585407 DOI: 10.1007/S12265-012-9373-8 |
0.305 |
|
| 2012 |
Esteghamati A, Morteza A, Khalilzadeh O, Anvari M, Noshad S, Zandieh A, Nakhjavani M. Physical inactivity is correlated with levels of quantitative C-reactive protein in serum, independent of obesity: results of the national surveillance of risk factors of non-communicable diseases in Iran. Journal of Health, Population, and Nutrition. 30: 66-72. PMID 22524121 DOI: 10.3329/Jhpn.V30I1.11278 |
0.327 |
|
| 2012 |
Nakhjavani M, Morteza A, Asgarani F, Khalilzadeh O, Ghazizadeh Z, Bathaie SZ, Esteghamati A. The dual behavior of heat shock protein 70 and asymmetric dimethylarginine in relation to serum CRP levels in type 2 diabetes. Gene. 498: 107-11. PMID 22349026 DOI: 10.1016/J.Gene.2012.01.085 |
0.33 |
|
| 2012 |
Esteghamati A, Zandieh A, Zandieh B, Khalilzadeh O, Esteghamati S, Meysamie A, Nakhjavani M. Comparing abilities of different lipid measures in diagnosis of insulin resistance: a Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) study. Metabolic Syndrome and Related Disorders. 10: 63-9. PMID 22010642 DOI: 10.1089/Met.2011.0002 |
0.309 |
|
| 2012 |
Bang JW, Khalilzadeh O, Wakeman D, Tamaki M, Hämäläinen M, Watanabe T, Sasaki Y. MEG oscillatory activity in the early visual areas during sleep and perceptual learning F1000research. 3. DOI: 10.7490/F1000Research.1090648.1 |
0.461 |
|
| 2012 |
Bang JW, Khalilzadeh O, Wakeman D, Tamaki M, Hamalainen M, Watanabe T, Sasaki Y. MEG slow activity in V1 during sleep and perceptual learning Journal of Vision. 12: 1125-1125. DOI: 10.1167/12.9.1125 |
0.459 |
|
| 2011 |
Nakhjavani M, Morteza A, Asgarani F, Mokhtari A, Esteghamati A, Khalilzadeh O, Rahbari G. Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients. Redox Report : Communications in Free Radical Research. 16: 193-200. PMID 22005339 DOI: 10.1179/1351000211Y.0000000008 |
0.365 |
|
| 2011 |
Esteghamati A, Noshad S, Khalilzadeh O, Morteza A, Nazeri A, Meysamie A, Esteghamati A, Nakhjavani M. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects. Archives of Medical Research. 42: 244-51. PMID 21722822 DOI: 10.1016/J.Arcmed.2011.05.005 |
0.329 |
|
| 2011 |
Morteza A, Nakhjavani M, Ghadiri-Anari A, Esteghamati A, Khalilzadeh O. Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes. European Cytokine Network. 22: 107-12. PMID 21636350 DOI: 10.1684/Ecn.2011.0282 |
0.326 |
|
| 2011 |
Esteghamati A, Morteza A, Khalilzadeh O, Noshad S, Novin L, Nakhjavani M. Association of serum cortisol levels with parameters of metabolic syndrome in men and women. Clinical and Investigative Medicine. Mã©Decine Clinique Et Experimentale. 34: E131-7. PMID 21631989 DOI: 10.25011/Cim.V34I3.15185 |
0.313 |
|
| 2011 |
Esteghamati A, Zandieh A, Zandieh B, Khalilzadeh O, Meysamie A, Nakhjavani M, Gouya MM. Leptin cut-off values for determination of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Endocrine. 40: 117-23. PMID 21384232 DOI: 10.1007/S12020-011-9447-4 |
0.315 |
|
| 2011 |
Nakhjavani M, Morteza A, Esteghamati A, Khalilzadeh O, Zandieh A, Safari R. Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes. Lipids. 46: 349-56. PMID 21153771 DOI: 10.1007/S11745-010-3513-1 |
0.313 |
|
| 2011 |
Esteghamati A, Alamdari A, Zandieh A, Elahi S, Khalilzadeh O, Nakhjavani M, Meysamie A. Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity. Diabetes Research and Clinical Practice. 91: 154-8. PMID 21122936 DOI: 10.1016/J.Diabres.2010.11.003 |
0.336 |
|
| 2011 |
Esteghamati A, Noshad S, Khalilzadeh O, Khalili M, Zandieh A, Nakhjavani M. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. Metabolic Syndrome and Related Disorders. 9: 111-7. PMID 21091060 DOI: 10.1089/Met.2010.0066 |
0.325 |
|
| 2011 |
Nakhjavani M, Asgharani F, Khalilzadeh O, Esteghamati A, Ghaneei A, Morteza A, Anvari M. Oxidized low-density lipoprotein is negatively correlated with lecithin-cholesterol acyltransferase activity in type 2 diabetes mellitus. The American Journal of the Medical Sciences. 341: 92-5. PMID 20890173 DOI: 10.1097/Maj.0B013E3181F3Ce10 |
0.342 |
|
| 2011 |
Nakhjavani M, Morteza A, Meysamie A, Esteghamati A, Khalilzadeh O, Esfahanian F, Khajeali L, Feiz F. Serum heat shock protein 70 and oxidized LDL in patients with type 2 diabetes: does sex matter? Cell Stress & Chaperones. 16: 195-201. PMID 20872261 DOI: 10.1007/S12192-010-0232-8 |
0.328 |
|
| 2010 |
Esteghamati A, Jamali A, Khalilzadeh O, Noshad S, Khalili M, Zandieh A, Morteza A, Nakhjavani M. Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. Diabetology & Metabolic Syndrome. 2: 65. PMID 21047423 DOI: 10.1186/1758-5996-2-65 |
0.353 |
|
| 2010 |
Esteghamati A, Zandieh A, Khalilzadeh O, Morteza A, Meysamie A, Nakhjavani M, Gouya MM. Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis. Endocrine. 38: 206-13. PMID 21046482 DOI: 10.1007/S12020-010-9374-9 |
0.319 |
|
| 2010 |
Esteghamati A, Ashraf H, Khalilzadeh O, Rashidi A, Rshidi A, Mohammad K, Asgari F, Abbasi M. Trends of diabetes according to body mass index levels in Iran: results of the national Surveys of Risk Factors of Non-Communicable Diseases (1999-2007). Diabetic Medicine : a Journal of the British Diabetic Association. 27: 1233-40. PMID 20950380 DOI: 10.1111/J.1464-5491.2010.03103.X |
0.33 |
|
| 2010 |
Esteghamati A, Khalilzadeh O, Ashraf H, Zandieh A, Morteza A, Rashidi A, Meysamie A, Nakhjavani M. Physical activity is correlated with serum leptin independent of obesity: results of the national surveillance of risk factors of noncommunicable diseases in Iran (SuRFNCD-2007). Metabolism: Clinical and Experimental. 59: 1730-5. PMID 20580780 DOI: 10.1016/J.Metabol.2010.04.016 |
0.309 |
|
| 2010 |
Nikzamir A, Rashidi A, Esteghamati A, Nakhjavani M, Golmohammadi T, Khalilzadeh O. The relationship between ACE gene insertion/deletion polymorphism and diabetic retinopathy in Iranian patients with type 2 diabetes. Ophthalmic Genetics. 31: 108-13. PMID 20565247 DOI: 10.3109/13816810.2010.482554 |
0.347 |
|
| 2010 |
Esteghamati A, Zandieh A, Khalilzadeh O, Meysamie A, Ashraf H. Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population. Diabetology & Metabolic Syndrome. 2: 36. PMID 20529329 DOI: 10.1186/1758-5996-2-36 |
0.325 |
|
| 2010 |
Nakhjavani M, Morteza A, Khajeali L, Esteghamati A, Khalilzadeh O, Asgarani F, Outeiro TF. Increased serum HSP70 levels are associated with the duration of diabetes. Cell Stress & Chaperones. 15: 959-64. PMID 20496051 DOI: 10.1007/S12192-010-0204-Z |
0.347 |
|
| 2010 |
Nakhjavani M, Karimi-Jafari H, Esteghamati A, Khalilzadeh O, Asgarani F, Ghadiri-Anari A. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity. Annales D'Endocrinologie. 71: 303-8. PMID 20434720 DOI: 10.1016/J.Ando.2010.02.026 |
0.36 |
|
| 2010 |
Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutrition & Metabolism. 7: 26. PMID 20374655 DOI: 10.1186/1743-7075-7-26 |
0.325 |
|
| 2010 |
Nakhjavani M, Khalilzadeh O, Khajeali L, Esteghamati A, Morteza A, Jamali A, Dadkhahipour S. Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol. Lipids. 45: 321-7. PMID 20224977 DOI: 10.1007/S11745-010-3401-8 |
0.354 |
|
| 2010 |
Esteghamati A, Rashidi A, Khalilzadeh O, Khalilzedeh O, Ashraf H, Abbasi M. Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes. Acta Diabetologica. 47: 125-30. PMID 19479185 DOI: 10.1007/S00592-009-0141-4 |
0.348 |
|
| 2009 |
Esteghamati A, Khalilzadeh O, Rashidi A, Meysamie A, Haghazali M, Asgari F, Abbasi M, Rastad S, Gouya MM. Association between physical activity and insulin resistance in Iranian adults: National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Preventive Medicine. 49: 402-6. PMID 19744508 DOI: 10.1016/J.Ypmed.2009.09.005 |
0.3 |
|
| 2009 |
Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, Kamgar M, Gouya MM, Abbasi M. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. Bmc Public Health. 9: 167. PMID 19480675 DOI: 10.1186/1471-2458-9-167 |
0.312 |
|
| 2009 |
Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M. Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metabolic Syndrome and Related Disorders. 7: 447-52. PMID 19419266 DOI: 10.1089/Met.2008.0100 |
0.312 |
|
| 2009 |
Esteghamati A, Ashraf H, Esteghamati AR, Meysamie A, Khalilzadeh O, Nakhjavani M, Abbasi M. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance. Diabetes Research and Clinical Practice. 84: 279-87. PMID 19359063 DOI: 10.1016/J.Diabres.2009.03.005 |
0.316 |
|
| 2009 |
Nakhjavani M, Esteghamati A, Asgarani F, Khalilzadeh O, Nikzamir A, Safari R. Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study. Translational Research : the Journal of Laboratory and Clinical Medicine. 153: 86-90. PMID 19138653 DOI: 10.1016/J.Trsl.2008.11.009 |
0.315 |
|
| 2008 |
Esteghamati A, Khalilzadeh O, Anvari M, Ahadi MS, Abbasi M, Rashidi A. Metabolic syndrome and insulin resistance significantly correlate with body mass index. Archives of Medical Research. 39: 803-8. PMID 18996295 DOI: 10.1016/J.Arcmed.2008.08.004 |
0.319 |
|
| 2008 |
Esteghamati A, Khalilzadeh O, Abbasi M, Nakhjavani M, Novin L, Esteghamati AR. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 30: 297-307. PMID 18633753 DOI: 10.1080/10641960802269919 |
0.348 |
|
| Show low-probability matches. |